Reminder: DUA and VRDC access needs to be extended or renewed annually. Read more.
SAS Name
NODAL_DISEASE
Nodal disease staging.
Source: Oncology Care Model Data Registry
Code | Code value |
---|---|
None Selected | |
N0 | |
N0(i+) | |
N0a | |
N0b | |
N1 | |
N1a | |
N1b | |
N1c | |
N1mi | |
N2 | |
N2a | |
N2b | |
N2c | |
N2mi | |
N3 | |
N3a | |
N3b | |
N3c | |
NX | |
pN0 | |
pN0(i+) | |
pN0(i-) | |
pN0(mol+) | |
pN0(mol-) | |
pN1 | |
pN1a | |
pN1b | |
pN1c | |
pN1mi | |
pN2 | |
pN2a | |
pN2b | |
pN2c | |
pN3 | |
pN3a | |
pN3b | |
pN3c | |
pNX | |
Null/missing | n/a (not required for cancer type); or not reported by OCM participant (reference details in the RPTD_TO_RGSTRY codebook entry) |
Practices were required to report clinical and staging data associated with each beneficiary’s assigned cancer. Nodal Disease (N) category describes the regional lymph node involvement as defined for each cancer site. It may include the absence or presence of cancer in regional nodes and/or the number of positive nodes, size, or involvement.
Nodal disease reporting was required for breast cancer, female GU other than ovarian cancer, gastro-esophageal cancer, kidney cancer, malignant melanoma, ovarian cancer, pancreatic cancer, and prostate cancer, and for the following cancer types for specific diagnosis codes: